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Short communication 
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Abstract 
fl-Amyloido 42) peptide ( flAP 0 _42)) was injected into the medial septum of rats. After a 14-day survival time, neuronal alterations in
the septal cholinergic and GABAergic systems were visualized by means of histo- and immunocytochemical methods. Neurons insulted 
by the peptide were primarily choline acetyltransferase-immunoreactive (ir), while only minor effects of flAP~v4: ) were observed on 
parvalbumin-ir interneurons. These results indicate that the changes in intracellular Ca 2+ level elicited by flAP(l_42 ) may contribute to 
/3-amyloid neurotoxicity, and Ca2+-binding proteins may play an important role in the protection against he neurotoxic effects of 
~AP, 421. 
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The sole invariant hallmark of Alzheimer's disease 
(AD) is the presence and excessive accumulation of /3- 
amyloid peptides (/3AP) forming neuritic plaques [21]. 
Alternative processing of the amyloid precursor protein 
liberates potentially amyloidogenic /3AP [22] that consist 
of 39-42 amino acid residues [12]. Small amounts of /3AP 
exert trophic properties on neurons in culture [25], while 
treatment of neurons with high concentrations of these 
proteins causes neurodegeneration and cell death in vitro 
[16,25]. Recent studies have shown that in vivo administra- 
tion of /3AP elicits the malfunction of neurons, leading, 
for instance, to a reduced acetylcholine release of neurons 
from the medial septum (MS) of rats [1]. The precise 
mechanism of how /3AP accumulation and deposition in- 
duce neuronal changes in the early stages of AD is still 
sketchy [17,21], but it has recently emerged that these 
peptides exhibit cholinotoxicity [1,13], contributing di- 
rectly to the impairment of cognitive, learning and memory 
functions in AD. Contemporary results, however, support 
the hypothesis that /3AP act by altering intracellular Ca 2+ 
concentrations ([Ca 2+ ]i) [17,18], while a Ca 2+ overload is 
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known to be toxic to neurons [6]. Thus, /3AP may also 
render neurons vulnerable (directly or indirectly) to differ- 
ent kinds of intracellular insults by disrupting normal 
intracellular Ca 2 + homeostasis. 
The MS plays an important role in learning and mem- 
ory processes via the septo-hippocampal pathway [11]. 
Primarily cholinergic and y-aminobutyric acid 
(GABA)ergic neurons, in approximately equal quantities, 
are situated in the MS of rats [23]. GABAergic neurons in 
the MS contain the Ca2+-binding protein parvalbumin 
(PV) [9], which plays a principal role in buffering the 
cytosolic free Ca 2+ levels [2,5]. While pathogenic changes 
in the cholinergic system can readily be demonstrated in 
the early stages of AD [3,21], PV-immunoreactive (ir) 
neurons represent a neuronal subset more resistant to 
degeneration i  AD [14]. 
Since controversial results have recently been published 
as to whether flAP may have specific effects on different 
populations of neurons in vitro [15,20], we have deter- 
mined the effects of one such peptide on septal cholinergic 
and GABAergic, PV-containing neurons in vivo. 
The synthesis of human fl-amyloido_42 ~ peptide 
(/3AP¢1-42)) has been previously described in detail [13]. In 
brief, /3AP(l_42 ) was synthesized with amide at the C- 
.terminal by a solid-phase technique involving Boc chem- 
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istry. Peptide chains were elongated on MBHA resin (0.6- 
0.8 mmol/g)  and the syntheses were carried out manually. 
Couplings were performed with dicyclohexylcarbodiimide, 
with the exception of Asn, which was incorporated in 
HOBt-ester form. The Boc group was removed by treat- 
ment with 50% trifluoroacetic acid (TFA) in CHzCi 2. 
After completion of the synthesis, the peptide was cleaved 
from the resin with liquid HF. Free peptides were solubi- 
lized in 95% TFA, filtered and lyophilized. The crude 
peptides were purified by reverse-phase high pressure liq- 
uid chromatography (RP-HPLC) on an Astec-300-5 C 4 
column. The purity was checked by RP-HPLC on a W- 
Porex-5 C 4 column. Amino acid analysis demonstrated the 
expected amino acid composition, and electrospray mass 
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Fig. 1. Representative photomicrographs of /3AP~l_42)-injected (A,C,D,F) and control animals (B,E,G). Silver impregnation, specific for terminal 
neurodegeneration [10], revealed extensive damage to the neurons after/3AP~1-42) treatment (A), while only the track of the needle (arrows) was labelled in 
control animals (B) as they are shown on dark-field photomicrographs. ChAT-immunolabelling demonstrated neuronal toss (C), perikaryal shrinkage 
(asterisk) and beaded fibres (arrowheads) of cholinergic neurons in the MS (D) after /3A1~1_42 ) administration, while the PV-immunoreactive n urons 
remained unaffected (F), relative to controls (E,G; bright-field photomicrographs C-G, respectively). A slight decrease in PV-immunoreactivity was rarely 
observed after /3AP<] 42~ treatment (F, arrows). Enlargement (D) of the area from C is indicated by the box. Scale bars = 33(1 /~m (A,B); 16(1 ~m 
(C,E,F,G); 25 #m (D). 
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spectrometry gave the expected molecular ion. lAP(l_42 ) 
was dissolved in 30% acetonitrile containing 0.1% TFA 
when used in the experiments. 
Ten male Wistar rats (320-370 g), divided into two 
groups (5 control and 5 treated animals), were used in 
these experiments. The animals were injected with 1 /xl of 
0.35 nmol/1 /xl fAP(l_42 ) into the MS (~ 0.1 /zl/min; 
AP = 0.2 mm, L = 0.3 mm, H = 6.0 mm from the bregma 
at an angle of 5 °, [19]), under 0.12 ml 6% sodium pento- 
barbital (i.p.)/0.12 ml Hypnorm (i.m., Janssen, The 
Netherlands)/0.1 ml methyl atropine sulfate (i.p.) anaes- 
thesia. Control animals received the same volume of the 
organic solvent only. After a 14-day survival time, all rats 
were deeply anaesthetized with 6% sodium pentobarbital 
and transcardially perfused with a 50 ml prerinse of hep- 
arinized saline. This was followed by 300 ml fixative 
containing 3% paraformaldehyde (PFA) and 0.2% picric 
acid solution. Brains were cryoprotected overnight at 4°C 
in 30% phosphate-buffered sucrose. Coronal cryostat sec- 
tions (20/.Lm) were cut and collected in phosphate-buffered 
saline (PBS; 0.01 M, pH 7.4). Silver staining was per- 
formed according to the method of Gallyas et al. [10]. 
Briefly, the cortical sections were postfixed overnight in 
4% PFA, then pretreated in a solution of 2% NaOH and 
2.5% NHaOH, followed by impregnation in a mixture 
containing 0.5% AgNO 3, 0.8% NaOH and 2.5% NHaOH. 
After the sections had been rinsed several times in a 
solution of 0.01% NH4NO 3 and 0.5% NazCO 3 in 30% 
ethanol, staining was developed in a solution containing 
0.01% citric acid, 0.5% formaldehyde and 10% ethanol. 
After washing of the sections everal times in 0.5% acetic 
acid, the reaction was stopped with Na2S20 3. 
Tissue sections processed for choline acetyltransferase 
(CHAT; EC 3.2.1.6) immunocytochemistry were rinsed 
several times in 0.01 M PBS, immersed in 0.3% H20 2 in 
PBS, rinsed again and incubated for 1 h at room tempera- 
ture (RT) in 5% normal rabbit serum (NRS; Zymed, San 
Francisco, CA, USA) diluted in 0.2% Triton X-100 and 
azide-containing PBS under gentle movement of the incu- 
bation medium. Free-floating sections were incubated with 
goat anti-ChAT IgG, as primary antibody (kindly donated 
by Dr. L.B. Hersh [4]) diluted 1:2000 in 1% NRS and 
0.2% Triton X-100 at 37°C for two days. After incubation, 
sections were thoroughly rinsed in PBS, preincubated for 1 
h with NRS, followed by the second antibody incubation 
for 1.5 h at 37°C. The second antibody was rabbit anti-goat 
IgG (1:80; Sigma, St. Louis, MO, USA). Sections were 
rinsed overnight in PBS before the third incubation step (2 
h at RT) in goat peroxidase-anti-peroxidase (PAP; 1:300; 
Dakopatts, Glosstrup, Denmark), diluted in Triton X-100- 
PBS. Finally, the peroxidase was visualized with 3,3'-di- 
aminobenzidine (DAB) as chromogen (30 mg/100 ml) 
and 0.01% H202. Between incubation steps, brain samples 
immunostained for PV were always rinsed at least four 
times with PBS to which 0.5% Triton X-100 had been 
added. Prior to the first antibody incubation, sections were 
exposed to 0.1% H202 for 15 min and 5% normal sheep 
serum (NSS; Jackson, West Grove, PA, USA) for 30 min 
at RT. Sections were then incubated overnight at 4°C with 
the primary monoclonal antibody, mouse anti-PV IgG 
(1:2000; Sigma), which recognizes the Ca2+-bound confor- 
mation of PV. After rinsing, sections were again incubated 
for 30 min in 5% NSS and exposed to biotinylated sheep 
anti-mouse IgG (1:200 in PBS, 2 h at RT; Amersham, 
Bucks, UK) and streptavidin-HRP (1:200 in PBS, 1 h at 
RT; Zymed, USA). Tissue-bound peroxidase was visual- 
ized by means of the same DAB-H202 reaction as de- 
scribed above. Standard control experiments were per- 
formed by omission of the primary antibodies, which did 
not yield any detectable immunoprecipitate (data not 
shown). 
After a 14-day survival time silver staining of MS 
sections revealed extensive degenerating processes in 
fAP(l_42)-treated animals as compared with the controls 
(Fig. 1A,B). Degenerating fibers were scattered throughout 
the MS (Fig. 1A) and they also appeared in efferent 
pathways (e.g. in the medial forebrain bundle; data not 
shown). In the control animals, only the needle-track was 
densely stained (Fig. 1B), revealing the effects of the 
operation trauma. The loss of the ChAT-it neurons and a 
marked decrease in ChAT-immunoreactivity were ob- 
served after fAP(l 42) treatment, as compared with the 
control animals (Fig. 1C,D,E). As a result of neurodegen- 
erative processes, the ChAT-ir neurons exhibited perikaryal 
shrinkage, while the degenerating and ChAT-ir processes 
had a beaded appearance, which is a characteristic feature 
of degenerating fibers (Fig. ID). While the ChAT-ir neu- 
rons were clustered in the lateral zone and in the midline 
area of the MS, the PV-containing GABAergic interneu- 
rons were situated in its central portion. In spite of the fact 
that the central area of the MS was primarily damaged 
during the injection procedure, the PV-positive neurons 
displayed only a limited change after injection of lAP(l_42), 
relative to the controls (Fig. 1F,G). Alteration of the PV-ir 
neurites rarely occurred, and only a slight decrease in 
PV-immunoreactivity was observed after /3AP(~_42 ) treat- 
ment. These changes were inconspicuous when compared 
to the characteristic degenerative changes in the ChAT-it 
neurons. 
Quantitative analysis of septal sections revealed a sig- 
nificant loss of ChAT-ir neurons after/3AP o_42) injections, 
as compared with the controls (46.71 + 9.1 vs. 62_  6.4 
neuron/MS, P < 0.01; Fig. 2). Analysis of our data re- 
vealed a slight decrease in the number of PV-ir septal 
neurons, albeit not significant in comparison with the 
controls (54.25 + 2.9 vs. 56.63 + 4.4 neuron/MS; Fig. 2). 
The observations yielded by silver- and ChAT-im- 
munolabelling in the present study are consistent with 
previous in vivo data of ourselves [13] and others [1], 
suggesting that flAP exert toxic effects on cholinergic 
neurons when injected into the rat brain. Analogous with 
the present results, Dong et al. [7] reported that intracere- 
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Fig. 2. Quantitati'~e analysis of ChAT-it and PV-ir neurons in the MS 
after /3AP~I ~z~ treatment. /3APtl 42i injection decreased the number of 
ChAT-ir neurons ignificantly (P < 1).1)1), while the number of PV-ir 
neurons was reduced only slightly. For quantitative analysis, sections 
throughout the MS were collected (at the AP coordinate 0.5-0.1 mm 
[19]). ChAT-it and PV-ir neurons were counted per MS (n = 4 animals 
per group in at least wo adjacent sections). Data were evaluated with 
Student's t-test, with statistical significance defined as P < 0.05, with 
Microsoft Excel 5.0 (Microsoft Co.. Redmond, WA, USA). 
protein may contribute to the prevention of neurodegenera- 
tion which results form [Ca 2+ ]i overload. It is noteworthy, 
however, that PV-ir neurons may also be affected by 
13AP~1_42 ~ but changes of PV gene expression may mask 
this neuronal damage by upregulation of the synthesis of 
the peptide. 
In summary, the present report provides histochemical 
evidence that /3APCj 42), the major amyloid component of 
neuritic plaques, induces a specific cellular injury of septal 
cholinergic neurons, whereas the GABAergic,  PV-positive 
neurons were relatively spared. As PV has been shown to 
be present within most of the GABAergic interneurons of 
the ms [9], our in vivo results support the observations thal 
GABAergic neurons are resistant to /3AP neurotoxicity 
[20]. Since the GABAergic neurons are so richly provided 
with the Ca2+-binding protein, this characteristic supports 
the hypothesis of deranged [Ca2+]i homeostasis in /3AP 
induced cell damage. For that reason the cholinergic neu- 
rons in the MS are more sensitive to /3AP induced dam- 
age. 
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broventricular infusion of AF64A reduced the number of 
ChAT-ir  neurons in the MS, while PV-ir interneurons 
remained unaffected. Moreover, it has recently been re- 
ported that GABAergic  neurons are resistant o /3AP neu- 
rotoxicity in vitro [20]. Histochemical analysis of AD 
brains corroborates these results, as PV-containing popula- 
tions of neurons seemed to be preserved in AD [14]. For 
example, Ferret et al. [8] reported that PV-ir dystrophic 
neurites and aberrant terminal sprouts had been found 
associated with senile plaques, while the density of the 
PV-ir neurons in the cerebral cortex remained unaffected 
in AD. These data support our present observations in rats, 
as the PV-ir neurons of the MS seemed to be less affected 
after/3AP{~_ 42) treatment, although some changes occurred 
in the PV-ir neurites. It is interesting to speculate as to the 
role of the Ca 2 +-binding protein PV in the prevention of 
/3AP neurotoxicity. We have therefore focused our atten- 
tion on the role of PV in the protection of neurons against 
/3AP neurotoxicity, via buffering of the [Ca 2+]i. As out- 
lined earlier [17], /3AP toxicity is mediated by alterations 
in the Ca 2~ homeostasis of the neurons. In addition, the 
Ca 2+ channel blocker nimodipine was able to attenuate the 
effects of /3AP [24], suggesting the principal role of the 
Ca 2+ overload in /3AP-induced neurotoxicity. PV is known 
to regulate [Ca 2~ ]~ through the active binding of free, 
cytosolic Ca -'~ . This regulatory role of the Ca2+-binding 
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